IRIS
FURLANUT, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.076
AS - Asia 2.284
EU - Europa 1.792
SA - Sud America 276
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 11.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.988
SG - Singapore 1.134
CN - Cina 551
UA - Ucraina 545
DE - Germania 297
HK - Hong Kong 255
BR - Brasile 243
SE - Svezia 191
IT - Italia 189
RU - Federazione Russa 158
FI - Finlandia 154
IE - Irlanda 97
TR - Turchia 93
VN - Vietnam 74
CA - Canada 59
GB - Regno Unito 59
IN - India 51
KR - Corea 42
BE - Belgio 20
BD - Bangladesh 19
FR - Francia 16
MX - Messico 16
IR - Iran 15
ES - Italia 12
ZA - Sudafrica 12
AR - Argentina 9
NL - Olanda 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
JP - Giappone 8
PL - Polonia 7
EU - Europa 5
IQ - Iraq 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CO - Colombia 4
ID - Indonesia 4
IL - Israele 4
AL - Albania 3
AT - Austria 3
AZ - Azerbaigian 3
BB - Barbados 3
MA - Marocco 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
TH - Thailandia 3
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KE - Kenya 2
LU - Lussemburgo 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
TG - Togo 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 11.462
Salva come PNG Salva come JPEG
Città #
Fairfield 879
Ann Arbor 674
Woodbridge 647
Ashburn 573
Singapore 531
Chandler 490
Houston 436
Wilmington 351
Seattle 350
Jacksonville 347
Beijing 292
Cambridge 284
Hong Kong 255
Dearborn 212
Boardman 130
Princeton 98
Dublin 96
Udine 87
Izmir 86
New York 80
Los Angeles 71
Des Moines 58
San Diego 52
Munich 49
Buffalo 43
Dallas 34
Seoul 31
Ottawa 30
Hefei 29
Redondo Beach 27
Hanoi 26
Ogden 22
Ho Chi Minh City 21
Brussels 20
Mumbai 18
Nanjing 18
Santa Clara 17
São Paulo 17
Brooklyn 16
San Mateo 15
Turku 15
Kunming 14
Denver 13
Jinan 12
Falls Church 11
Leawood 11
Augusta 10
Boston 10
Guangzhou 10
Norwalk 10
Orem 10
San Francisco 10
Shanghai 10
Atlanta 9
Helsinki 9
Mexico City 9
Monmouth Junction 9
Montreal 9
Rome 9
Trieste 9
Belo Horizonte 8
Brno 8
Düsseldorf 8
London 8
Nanchang 8
Tokyo 8
Naples 7
Poplar 7
Warsaw 7
Winnipeg 7
Brasília 6
Dhaka 6
Hebei 6
Johannesburg 6
Phoenix 6
Rio de Janeiro 6
Changsha 5
Da Nang 5
Grafing 5
Milan 5
Moscow 5
Padova 5
Wenzhou 5
Wuhan 5
Amsterdam 4
Ankara 4
Ardabil 4
Bologna 4
Campinas 4
Indiana 4
Manchester 4
New Delhi 4
Secaucus 4
Simi Valley 4
Stockholm 4
Toronto 4
Andover 3
Annapolis 3
Baku 3
Bridgetown 3
Totale 7.933
Salva come PNG Salva come JPEG
Nome #
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 191
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 184
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 180
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 179
Chlorpromazine disposition in relation to age in children 178
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 171
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 163
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 162
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 157
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 155
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 152
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 151
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 151
Determination of tamoxifen and its metabolites in the endometrial tissue of long term treated women 151
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 150
Side effects of imipramine therapy in enuretic children. 147
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 147
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 146
Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation 143
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 141
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 139
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 138
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 138
Effect of fluctuations of blood cyclosporine concentrations on renal function. 137
Blood concentrations and clinical effect of cyclosporin in psoriasis 137
Calculating percentage prediction error: a user's note 137
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 137
Chronopharmacokinetics of ciclosporin and tacrolimus 136
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 136
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 134
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 133
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 132
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 132
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 132
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 131
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 131
A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients 129
Pharmacology of ifosfamide 128
Fluoxetine disposition in patients suffering from chronic hepatitis C treated with interferon alpha 128
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 128
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 127
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 127
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 126
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 125
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 125
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 125
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 125
Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation 124
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 123
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 123
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 123
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 121
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 120
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 118
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy 117
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 117
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 115
Imipramine pharmacokinetics in depressed geriatric patients 114
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient 113
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose 112
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy 111
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 110
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis 109
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 107
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients 106
Isoniazid and its hydrazine metabolite in patients with tuberculosis 106
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 105
MEGX disposition in critically-ill trauma patients: Subsequent assessments during the first week following trauma 105
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 102
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 101
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients 101
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration 100
Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women 99
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 98
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 97
Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers 94
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 92
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 92
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 91
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 89
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 89
Un caso di encefalite da Mycoplasma pneumoniae trattato con levofloxacina 88
Farmacologia generale e clinica per le lauree sanitarie - III Edizione - Ed. Piccin 87
Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients? 86
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 85
Oral and intravenous disposition of cyclosporine in psoriatic patients. 84
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 84
Pharmacokinetic aspects of levofloxacin 500 mg once-daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections 83
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 82
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages 80
Farmacologia - Principi e applicazioni 78
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 73
Farmacologia generale e clinica per le lauree sanitarie - II edizione 72
Variability in the metabolism of levodopa and clinical implications 69
Farmacologia generale e clinica per le lauree triennali 66
Personalization of antimicrobial dosing regimens: Indicators of performance 66
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 66
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients 53
Totale 11.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021811 0 0 0 0 0 157 48 137 173 49 181 66
2021/2022941 40 68 47 89 48 50 43 42 15 154 209 136
2022/20231.021 112 90 18 127 132 276 0 74 130 13 20 29
2023/2024319 55 23 7 5 60 72 6 19 36 6 2 28
2024/20251.656 40 110 104 45 73 87 89 107 139 117 312 433
2025/20261.767 295 356 236 276 522 82 0 0 0 0 0 0
Totale 11.698